市場調査レポート
商品コード
1439518
尿失禁デバイス - 世界市場の考察、競合情勢、市場予測(2030年)Urinary Incontinence Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
尿失禁デバイス - 世界市場の考察、競合情勢、市場予測(2030年) |
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の尿失禁デバイスの市場規模は、2023年に29億7,000万米ドル、2030年までに43億米ドルに達し、2024年~2030年の予測期間にCAGRで6.36%の成長が見込まれます。尿失禁症例の有病率の上昇、革新的なデバイスの開発、尿路感染症などの泌尿器科疾患にかかりやすい老年人口、骨盤底の弱体化、妊娠、糖尿病、更年期障害、パーキンソン病などの疾患により、尿失禁デバイス市場は成長が見込まれています。
尿失禁デバイスの市場力学
尿失禁デバイス市場は、尿失禁の有病率の上昇により大幅に増加しています。National Association for Continence(2018)によると、3,300万人以上のアメリカ人が何らかの尿失禁や膀胱の病気を患っています。世界中で尿失禁の負担が増加しているため、尿失禁デバイス市場は大幅に伸びています。
また、尿失禁先進デバイスの開発は見事なペースで栄えています。例えば2020年2月、Atlantic Therapeuticsは、米国FDAがストレス性尿失禁(SUI)向けの非侵襲性デバイスであり、臨床的に証明されており、膀胱の弱さの根本原因を治療するウェアラブルデバイスであるINNOVO®に店頭販売(OTC)の許可を与えたと発表しました。INNOVO®はこれまで米国で処方箋により入手可能であり、世界中で350万回以上の安全かつ成功した治療が実施されています。このような尿失禁デバイスの分野における技術の進歩は、世界の尿失禁デバイス市場を押し上げる可能性が高いです。
また、老年人口は尿路感染症や骨盤底の弱体化といった泌尿器科疾患が発症するまでに、尿失禁を起こしやすくなります。Urology Centers of Alabama(2018)によると、過活動膀胱(OAB)は誰にでも起こりえますが、もっとも多い年齢は40歳以降の男性と、特に女性です。CentraState Healthcare System(2019)によると、40歳以上では女性の3人に1人が尿失禁の症状を経験し、世界中で60歳以上の女性の2人に1人が罹患しています。80歳以上の女性では、何らかの失禁がないほうが珍しいです。したがって、老年人口が増加するにつれて泌尿器科疾患の有病率は高まり、尿失禁市場の成長を後押しする見込みです。
COVID-19パンデミックの発生は世界中に大きな影響を与えました。このパンデミックは、外来受診のキャンセル、緊急性のない病院や処置の中断につながっています。その結果、泌尿器科の診察や関連処置の定期臨床検査が減少しました。そのため、手術を通じた尿失禁デバイスの入手を待つ患者は、時間の経過とともに増加しました。そのため、尿失禁デバイスの需要は予測期間に加速し、市場の成長促進要因となっています。
しかし、失禁や手術後の合併症に対する患者の意識の低さといった特定の要因が、世界の尿失禁デバイス市場の成長を抑制すると予測されます。
尿失禁デバイス市場のセグメント分析
尿失禁デバイス市場の製品セグメントでは、尿道スリング市場セグメントが世界の尿失禁デバイス市場で大きなシェアを占める見込みです。この製品セグメントの大きな市場シェアは、迅速な救援のためにこれらのデバイスを採用する患者が増加していることに起因しています。さらに、尿道スリングは先進のデバイスであり、市場で入手可能な従来のデバイスすべてに取って代わっています。
さらに、これらのスリングは患者から採取した靭帯、組織、腱などのさまざまな材料で構成されていますが、プラスチックなどの合成材料で製造することもできます。
女性の尿失禁の有病率が上昇していることも、尿道スリング手術の需要を高めています。さらに、尿失禁の分野で行われている重要な研究活動が、結果として市場を押し上げる見込みです。
さらに、患者の間で従来のデバイスから先進のデバイスへの動向の変化が見られます。これにより、尿失禁デバイスの患者への受容性が高まります。したがって、上記のすべての要因が尿失禁デバイス市場の成長を促進すると予測されます。
当レポートでは、世界の尿失禁デバイス市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。
Urinary Incontinence Devices Market By Product (Urinary Catheters, Urethral Slings, Electrical Stimulation Devices, Artificial Urinary Sphincters, Others), By Type (External Devices, Internal Devices), By Patient Type (Male, Female), By End-User (Hospitals And Clinics, Ambulatory Surgery Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2030 owing to the development of innovative devices and and surge in urological conditions.
Global Urinary Incontinence Devices Market was valued at USD 2.97 billion in 2023, growing at a CAGR of 6.36% during the forecast period from 2024 to 2030, to reach USD 4.30 billion by 2030. The Urinary Incontinence Devices market is expected to witness growth due to the rising prevalence of urinary incontinence cases, development of innovative devices, aging population prone to urological conditions like urinary tract infections, weakening of pelvic floor, and conditions including pregnancy, diabetes, menopause, and Parkinson's disease.
Urinary Incontinence Devices Market Dynamics:
Urinary Incontinence Devices Market has significantly increased due to the rising prevalence of urinary incontinence cases. As per the National Association for Continence 2018, over 33 million Americans suffer from some type of urinary incontinence or bladder condition. Owing to the growing burden of urinary incontinence across the globe, the Urinary Incontinence Devices market has been rising significantly.
In addition, the development of urinary incontinence advanced devices is thriving at a great pace. For instance, in February 2020, Atlantic Therapeutics announced that the US FDA granted over-the-counter (OTC) clearance to INNOVO®, a non-invasive device for non-invasive device for stress urinary incontinence (SUI), clinically proven, and wearable device that treats the root cause of bladder weakness. INNOVO® was previously available in the US by prescription, with more than 3.5 million safe and successful therapy sessions delivered worldwide. Such technological advancement in the field of Urinary Incontinence Devices is likely to boost the Global Urinary Incontinence Devices Market.
Also, the aging population is more prone to urinary incontinence, by the time urological conditions like urinary tract infections and weakening of pelvic floor develop. According to the Urology Centers of Alabama 2018, although overactive bladders (OAB) can happen to anyone, the most common ages are post-40 for men and, especially, women. According to the CentraState Healthcare System, 2019, over the age of 40, one in three women experience symptoms of urinary incontinence, while it affects one in two women over age 60 globally. For women age 80 and older, it's rare not to have some type of incontinence. Therefore, as the aging population increases, there will be more prevalence of urological conditions, which will eventually boost the growth of the Urinary Incontinence market.
The outbreak of the COVID-19 pandemic had a profound impact across the globe. The pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitals and procedures. This resulted in the reduced number of routine clinical examinations of the urological visits and related procedures. Thus, the number of patients waiting to get urinary incontinence devices through surgery increased over time. Therefore, the demand for Urinary Incontinence Devices has accelerated over the forecast period which will drive the market growth.
However, certain factors like less awareness among the patient population regarding incontinence and post-operative complications are expected to restrict the growth of the Global Urinary Incontinence Devices Market.
Urinary Incontinence Devices Market Segment Analysis:
Urinary Incontinence Devices Market by Product (Urinary Catheters, Urethral Slings, Electrical Stimulation Devices, Artificial Urinary Sphincters, Others), by Type (External Devices, Internal Devices), by Patient Type (Male, Female), by End-User (Hospitals and Clinics, Ambulatory Surgery Centers, Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
Urinary Incontinence Devices market product segment, the Urethral Slings market segment will hold the major share of the Global Urinary Incontinence Devices market. The large market share of this product segment can be attributed to the growing patient adoption for these devices due to quick relief. Moreover, Urethral Slings are more advanced devices and have replaced all the conventional devices available in the market.
Furthermore, these slings are made up of different materials like ligament, tissue, tendons taken from the patient or they can also be manufactured from synthetic sources like plastic.
The rising prevalence of urinary incontinence among the women population is also increasing the demand for urethral sling surgery. Moreover, the significant research activities taking place in the Urinary Incontinence arena will eventually boost the market.
Additionally, a shift in trend from conventional devices to advanced devices can be seen among the patient population. This will increase the acceptance of Urinary Incontinence Devices for patients. Hence, all the above-mentioned factors are expected to drive the segment growth of the Urinary Incontinence Devices market.
North America Is Expected To Dominate The Overall Global Urinary Incontinence Devices Market:
North America is expected to dominate the overall Urinary Incontinence Devices market during the forecast period. This domination is due to the rising prevalence of urinary incontinence cases and urological conditions among men and women in the region. As per Urology Care Foundation 2022, a quarter to a third of men and women in the US suffer from urinary incontinence. About 33 million have overactive bladder representing symptoms of urgency, frequency, and urge incontinence.
According to the same statistics, as many as 30% of men and 40% of women in the United States live with OAB symptoms. Thus, the burgeoning cases of the diseases will contribute to the growth of the Urinary Incontinence Devices Market in the region as the demand will increase.
Further, in North America and at the global level the United States represents the largest market worldwide supported by the development of advanced devices and easy regulatory initiatives by the government. One such technological advancement is the development of implantable tibial neuromodulation (TNM) device designed to provide relief from symptoms of bladder incontinence, developed by Medtronic PLC. The device received approval from US FDA to proceed with an investigational device exemption (IDE) trial in April 2022.
Europe and Asia-Pacific region have the future potential growth for the Global Urinary Incontinence Devices market. This is owing to the rising burden of urological diseases and COVID-19 pandemic in the European region countries and Asian countries. Rising product launch and commercialization agreements among the key manufacturers and other companies are anticipated to boost the Urinary Incontinence Devices market. For instance, in April 2022, in Australia, Analytica Ltd. signed a joint venture agreement with Hebei Nacol Bio-Technology Co. Ltd. and Shijiazhuang Biosphere Pty Ltd., of Hebei Province, China, to manufacture and distribute its Pericoach device for urinary incontinence in China, Macau, Hong Kong, and Taiwan. Such initiatives are anticipated to boost the Urinary Incontinence Devices Market.
Urinary Incontinence Devices Market Key Players:
Some of the key market players operating in the Global Urinary Incontinence Devices Market include NeoTract, Inc., Cook Medical Inc., C.R. Bard Inc., Coloplast Corporation, Boston Scientific Corporation, Ethicon US, LLC, Medtronic PLC, A.M.I. Ltd., Teleflex Incorporated, Hollister Incorporated, ConvaTec Group PLC, Caldera Medical Inc., Prosurg, Inc., Laborie, Inc., Becton, Dickinson and Company, ZSI Surgical Implants, Atlantic Therapeutics, B. Braun Melsungen AG, Flexicare (Group) Limited, InControl Medical among others.
Recent Developmental Activities in the Urinary Incontinence Devices Market:
In September 2022, at American Urological Association Annual Meeting, a novel, ultra-miniaturized sacral nerve modulation (SNM) system was shown to be both efficacious and safe in treating patients with urge urinary incontinence (UUI), according to findings from the feasibility phase of the SANS-UUI study.
In May 2022, the University of Washington School of Medicine developed and tested 3 new devices to relieve symptoms of urinary incontinence. The first device tested in a clinical trial was a neuromodulation device. The second device involves an electrode about the size of a small pill and is implanted through a needle in the lower back alongside one of the main pelvic nerves. The third device is a soft, rubber ring with embedded electrodes placed in the vagina like a pessary or diaphragm.
Key Takeaways from the Urinary Incontinence Devices Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Urinary Incontinence Devices market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global Urinary Incontinence Devices Market.
Various opportunities are available for the other competitor in the Urinary Incontinence Devices Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Urinary Incontinence Devices market growth in the coming future?
Target Audience who can be benefited from this Urinary Incontinence Devices Market Report Study
Urinary Incontinence Devices providers
Research organizations and consulting companies
Urinary Incontinence Devices related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Urinary Incontinence Devices
Various End-users want to know more about the Urinary Incontinence Devices Market and the latest technological developments in the Urinary Incontinence Devices market.
Frequently Asked Questions for Urinary Incontinence Devices Market:
Urinary Incontinence Devices are medical devices that help in collecting and holding urine. Urinary Incontinence (UI) is a medical disorder in which a person unconsciously urinates. It is differentiated into four types namely, stress urinary incontinence, urge urinary incontinence, overflow urinary incontinence, and functional urinary incontinence.
Global Urinary Incontinence Devices Market was valued at USD 2.97 billion in 2023, growing at a CAGR of 6.36% during the forecast period from 2024 to 2030, to reach USD 4.30 billion by 2030.
The major drivers driving the demand for Urinary Incontinence Devices are the rising prevalence of urinary incontinence cases, the development of innovative devices, the aging population prone to urological conditions like urinary tract infections, weakening of pelvic floor, and conditions including pregnancy, diabetes, menopause, and Parkinson's disease.
Some of the key market players operating in the Urinary Incontinence Devices market include NeoTract, Inc., Cook Medical Inc., C.R. Bard Inc., Coloplast Corporation, Boston Scientific Corporation, Ethicon US, LLC, Medtronic PLC, A.M.I. Ltd., Teleflex Incorporated, Hollister Incorporated, ConvaTec Group PLC, Caldera Medical Inc., Prosurg, Inc., Laborie, Inc., Becton, Dickinson and Company, ZSI Surgical Implants, Atlantic Therapeutics, B. Braun Melsungen AG, Flexicare (Group) Limited, InControl Medical, and others.
North America is expected to dominate the overall global Urinary Incontinence Devices market during the forecast period from 2024 to 2030. This domination is due to the rising prevalence of urinary incontinence cases and urological conditions among men and women in the region.